{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:10:18Z","timestamp":1759734618274,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.prp.2012.11.003","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T22:48:30Z","timestamp":1362782910000},"page":"201-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Classical Hodgkin lymphoma, lymphocyte depleted type: Clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma"],"prefix":"10.1016","volume":"209","author":[{"given":"Kennosuke","family":"Karube","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Niino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshizo","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2012.11.003_bib0005","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"229","article-title":"Lymphocyte-depleted classical Hodgkin lymphoma","author":"Benharroch","year":"2009"},{"key":"10.1016\/j.prp.2012.11.003_bib0010","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM197304122881502","article-title":"Lymphocyte-depletion Hodgkin's disease. A clinicopathological entity","volume":"288","author":"Neiman","year":"1973","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2012.11.003_bib0015","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1200\/JCO.2005.17.970","article-title":"Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials","volume":"23","author":"Shimabukuro-Vornhagen","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2012.11.003_bib0020","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/cncr.21995","article-title":"Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups","volume":"107","author":"Allemani","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2012.11.003_bib0025","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1200\/JCO.1986.4.3.284","article-title":"The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease","volume":"4","author":"Kant","year":"1986","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2012.11.003_bib0030","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/10428190310001646022","article-title":"Prognostic factors in Hodgkin's disease","volume":"45","author":"Provencio","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2012.11.003_bib0035","first-page":"1150","article-title":"Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution","volume":"6","author":"Smolewski","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2012.11.003_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients","volume":"27","author":"Oyama","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2012.11.003_bib0045","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/(SICI)1097-0215(19970807)72:4<592::AID-IJC7>3.0.CO;2-L","article-title":"Clonal HTLV-I-infected CD4+ T-lymphocytes and non-clonal non-HTLV-I-infected giant cells in incipient ATLL with Hodgkin-like histologic features","volume":"72","author":"Ohshima","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2012.11.003_bib0050","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/1097-0142(19891015)64:8<1686::AID-CNCR2820640822>3.0.CO;2-I","article-title":"Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients","volume":"64","author":"MacLennan","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2012.11.003_bib0055","first-page":"4639","article-title":"Defective provirus form of human T-cell leukemia virus type I in adult T-cell leukemia\/lymphoma: clinicopathological features","volume":"51","author":"Ohshima","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2012.11.003_bib0060","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2012.11.003_bib0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/annonc\/mdj064","article-title":"Gene expression profile of cytokines and chemokines in microdissected primary Hodgkin and Reed\u2013Sternberg (HRS) cells: high expression of interleukin-11 receptor alpha","volume":"17","author":"Karube","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2012.11.003_bib0070","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1158\/0008-5472.CAN-06-0261","article-title":"Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege","volume":"66","author":"Ishida","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2012.11.003_bib0075","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","article-title":"The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4","volume":"272","author":"Imai","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2012.11.003_bib0080","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.185.9.1595","article-title":"Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells","volume":"185","author":"Godiska","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prp.2012.11.003_bib0085","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1158\/0008-5472.CAN-05-0100","article-title":"Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor","volume":"65","author":"Weihrauch","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2012.11.003_bib0090","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2006.06.5342","article-title":"Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study","volume":"24","author":"Asano","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2012.11.003_bib0095","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood.V94.9.3108","article-title":"Frequent expression of the B-cell-specific activator protein in Reed\u2013Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin","volume":"94","author":"Foss","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.prp.2012.11.003_bib0100","first-page":"675","article-title":"Association of Epstein\u2013Barr virus latent membrane protein and Hodgkin's disease in Mexico","volume":"8","author":"Quintanilla-Martinez","year":"1995","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2012.11.003_bib0105","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/1097-0142(19950315)75:6<1360::AID-CNCR2820750619>3.0.CO;2-U","article-title":"Hodgkin's disease in Mexico prevalence of Epstein\u2013Barr virus sequences and correlations with histologic subtype","volume":"75","author":"Zarate-Osorno","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2012.11.003_bib0110","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1200\/JCO.2005.01.701","article-title":"Impact of latent Epstein\u2013Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma","volume":"23","author":"Claviez","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2012.11.003_bib0115","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood.V94.2.442.414a46_442_447","article-title":"Effect of Epstein\u2013Barr virus infection on response to chemotherapy and survival in Hodgkin's disease","volume":"94","author":"Murray","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.prp.2012.11.003_bib0120","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/annonc\/mdg065","article-title":"The effect of Epstein\u2013Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's disease","volume":"14","author":"Flavell","year":"2003","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2012.11.003_bib0125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02786468","article-title":"The immune system in the elderly: III. Innate immunity","volume":"20","author":"Ginaldi","year":"1999","journal-title":"Immunol. Res."},{"key":"10.1016\/j.prp.2012.11.003_bib0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02786467","article-title":"The immune system in the elderly: II. Specific cellular immunity","volume":"20","author":"Ginaldi","year":"1999","journal-title":"Immunol. Res."},{"key":"10.1016\/j.prp.2012.11.003_bib0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02786466","article-title":"The immune system in the elderly: I. Specific humoral immunity","volume":"20","author":"Ginaldi","year":"1999","journal-title":"Immunol. Res."},{"key":"10.1016\/j.prp.2012.11.003_bib0140","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/10428190902930488","article-title":"Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis","volume":"50","author":"Slack","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2012.11.003_bib0145","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1200\/JCO.2011.36.4703","article-title":"Lymphocyte-depleted classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study group","volume":"29","author":"Klimm","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2012.11.003_bib0150","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2012.11.003_bib0155","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood-2007-05-086934","article-title":"HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV-positive Hodgkin lymphoma","volume":"110","author":"Niens","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.prp.2012.11.003_bib0160","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1200\/JCO.2006.10.0917","article-title":"HLA class II expression by Hodgkin Reed\u2013Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma","volume":"25","author":"Diepstra","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2012.11.003_bib0165","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1158\/1055-9965.EPI-06-0476","article-title":"The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes","volume":"15","author":"Niens","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.prp.2012.11.003_bib0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0609.2005.00452.x","article-title":"Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region","volume":"66","author":"Diepstra","year":"2005","journal-title":"Eur. J. Haematol. Suppl."},{"key":"10.1016\/j.prp.2012.11.003_bib0175","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/S0140-6736(05)66780-3","article-title":"Association with HLA class I in Epstein\u2013Barr-virus-positive and with HLA class III in Epstein\u2013Barr-virus-negative Hodgkin's lymphoma","volume":"365","author":"Diepstra","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2012.11.003_bib0180","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1182\/blood-2008-06-164806","article-title":"Age-related Epstein\u2013Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients","volume":"113","author":"Asano","year":"2009","journal-title":"Blood"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033812003287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033812003287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:33:44Z","timestamp":1759732424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033812003287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0344033812003287"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2012.11.003","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classical Hodgkin lymphoma, lymphocyte depleted type: Clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2012.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}